If you got a question, look no further.
We post the most common questions
in our FAQ section.
Please fill in the form below to receive a Free Sample of the Report.
BMI View: Strong output growth from fields associated with large LNG export
projects will allow PNG's net LNG exports to more than double over the next
decade. The country is on course to overtake Indonesia and Brunei, by 2022 and
2019 respectively, to become the third largest LNG exporter in Asia. Condensates
output from these gas developments will allow PNG to remain a net exporter of
crude oil and liquids, though under utilisation of existing refining capacity
means that the country remains dependent on fuels imports.
The main trends and developments we highlight for Papua New Guinea's oil and gas
-Oil Search is planning to take over InterOil for USD2.2bn. The deal will allow
both Total and Oil Search to increase stakes in the Papua LNG project,
demonstrating their confidence in the PNG LNG sector.
-Puma Energy is undertaking upgrade works at its Napa Napa refinery, following
months of closure, to improve the facility's feedstock flexibility and
production efficiency. The firm is also seeking government approval for a
potential capacity expansion, though under utilisation of existing capacity
suggests that this is unlikely to go through.
-Exxon Mobil is seeking to add a third train at its PNG LNG project by
developing the P'nyang field - for which a final investment decision is expected
to be given in 2017.
-PNG will remain a net exporter of crude oil and liquids. The country's Kutubu
Blend (now blended with condensates from PNG LNG) is sold to private trading
firms such as BP and Trafigura for sales into the regional market, including
Singapore and Australia.
BMI View: The presidential election result will maintain the attractiveness
of Peru's pharmaceutical and healthcare sector. A Fujimori administration will
further bolster Peru's business environment and encourage increasing investment
in Peru's pharmaceutical manufacturing sector. Government commitment to
healthcare will continue to improve domestic pharmaceutical consumption.
Headline Expenditure Projections
-Pharmaceuticals: PEN4.98bn (USD1.56bn) in 2015 to PEN5.32bn (USD1.61bn) in
2016; +6.8% in local currency terms and 3.0% in US dollar terms. Forecast
unchanged from previous quarter.
-Healthcare: PEN34.9bn (USD11.0bn) in 2015 to PEN38.5bn (USD11.7bn) in 2016;
+10.0% in local currency terms and 6.2% in US dollar terms. Forecast revised
upwards from previous quarter.